Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.130
0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
2.103
-0.027 (-1.25%)
After-hours: Jul 17, 2026, 4:30 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $1.77 million as of July 17, 2026. Its market cap has decreased by -27.11% in one year.
Market Cap
1.77M
Enterprise Value
-9.64M
1-Year Change
-27.11%
Ranking
Category
Stock Price
$2.13
ChartMarket Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $1.77M, a decrease of -98.27%. That is a compound annual growth rate of -42.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.77M | -7.27% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearmind Medicine | 2.82M |
| GRI Bio | 2.73M |
| Oragenics | 2.54M |
| Calidi Biotherapeutics | 2.34M |
| Bone Biologics | 2.15M |
| Azitra | 2.13M |
| Matinas BioPharma Holdings | 2.09M |
| VivoSim Labs | 1.96M |